Document Detail


Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
MedLine Citation:
PMID:  12595849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study was designed to assess whether testing of potential reversibility of pulmonary hypertension (PHT) may be a useful means of defining the short-term prognosis of patients with advanced heart failure and elevated pulmonary artery pressure. In such patients, the reversibility of PHT after acute vasodilator administration is associated with a low early mortality rate after heart transplantation. However, its short-term prognostic value has not yet been determined. METHODS AND RESULTS: Between 1994 and 1998, 76 patients with advanced heart failure and PHT underwent right heart cathetherization. The hemodynamic measurements, including thermodilution-derived right ventricular ejection fraction, were repeated after an intravenous bolus of nitroglycerin (NTG). During a median follow-up period of 8.2 months (25% and 75% centiles, 3.3 and 18.9 months), 47 patients had a cardiac event (death or urgent heart transplantation). With Cox survival analysis, a multivariate model that included the New York Heart Association class and the hemodynamic variables obtained after NTG administration allowed a better assessement of the short-term prognosis of the patients than a model including the baseline variables. The evaluation of right ventricular function during the acute NTG-induced pulmonary vasodilation was of critical importance in obtaining such a refinement in the prognostic stratification. CONCLUSIONS: The prognostic evaluation of patients with advanced heart failure and PHT should include the assessment of the changes of right ventricular ejection fraction after acute afterload reduction.
Authors:
Antonello Gavazzi; Stefano Ghio; Laura Scelsi; Carlo Campana; Catherine Klersy; Alessandra Serio; Claudia Raineri; Luigi Tavazzi
Related Documents :
125539 - Left main coronary arterial obstruction: long-term follow-up of 141 nonsurgical cases.
10890989 - Neonatal and infantile erythrodermas: a retrospective study of 51 patients.
7706629 - Immediate and long-term survival after intra-aortic balloon pumping: is advanced age an...
3529959 - Non-q-wave myocardial infarction.
9820989 - Improved long-term prognosis after myocardial infarction 1984-1991.
9358519 - Ventricular arrhythmias in dilated cardiomyopathy.
3639819 - Hemodynamic abnormalities in acute myocardial infarction.
433959 - Haemophilus parainfluenzae mitral valve vegetation without hemodynamic abnormality. dem...
17950789 - Percutaneous coronary intervention with off-site cardiac surgery backup for acute myoca...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  145     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-21     Completed Date:  2003-03-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  310-6     Citation Subset:  AIM; IM    
Affiliation:
Dipartimento di Cardiologia, IRCCS Policlinico S Matteo, Pavia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Analysis of Variance
Cardiotonic Agents
Female
Heart Catheterization / methods
Heart Failure / drug therapy*,  mortality,  physiopathology
Heart Transplantation
Hemodynamics / drug effects,  physiology
Humans
Hypertension, Pulmonary / drug therapy*,  mortality,  physiopathology
Male
Middle Aged
Nitroglycerin / therapeutic use*
Prognosis
Proportional Hazards Models
Stroke Volume / drug effects
Survival Analysis
Vascular Resistance / drug effects,  physiology
Vasodilator Agents / therapeutic use*
Ventricular Dysfunction, Left / complications
Ventricular Function, Right / drug effects*,  physiology
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Vasodilator Agents; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is specialty care associated with improved survival of patients with congestive heart failure?
Next Document:  New phenotype of familial dilated cardiomyopathy and conduction disorders.